Momenta Pharmaceuticals Inc $77,334,423 Alnylam Pharmaceuticals Inc $1,964,643 Horizon Pharma, Inc. $9,240,629 Momenta Pharmaceuticals Inc $77,334,423 Alnylam Pharmaceuticals Inc $1,964,643 Horizon Pharma, Inc. $9,240,629